Emmaus Life Sciences, Inc. ( EMMA) - Key Metrics
EMMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.09 | $0.02 | $0.02 | $0.02 |
| 2026Q1 | $0.03 | -$0.05 | $0 | $0 |
| 2025Q4 | $0.06 | -$0.03 | $0.03 | $0.03 |
| 2025Q3 | $0.05 | -$0.03 | $0.01 | $0.01 |
| 2025Q2 | $0.04 | -$0.02 | -$0.05 | -$0.05 |
EMMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.13 |
| 2026Q1 | 0% | -0.08 |
| 2025Q4 | 0% | -0.10 |
| 2025Q3 | 0% | -0.08 |
| 2025Q2 | 0% | -0.18 |
EMMA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 235.51% | 0% |
| 2026Q1 | -32.67% | 0% |
| 2025Q4 | 265.34% | 0% |
| 2025Q3 | 58.22% | 0% |
| 2025Q2 | -350.38% | 0% |
EMMA
Price: $0.05
52 week price:
Earnings Per Share: -0.12 USD
P/E Ratio: -0.12
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30500
Market Capitalization: 4.2 million